Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) General Information

Description

Rights to develop and commercialize praliciguat.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Cambridge, MA
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • Cambridge, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)‘s full profile, request access.

Request a free trial

Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)‘s full profile, request access.

Request a free trial

Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) FAQs

  • Where is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) headquartered?

    Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is headquartered in Cambridge, MA.

  • What industry is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) in?

    Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)’s primary industry is Buildings and Property.

  • Is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) a private or public company?

    Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is a Private company.

  • What is the current valuation of Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)?

    The current valuation of Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is .

  • What is Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)’s current revenue?

    The current revenue for Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) is .

  • Who are Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)’s investors?

    Cyclerion has invested in Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat).

  • When was Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) acquired?

    Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) was acquired on 04-Jun-2021.

  • Who acquired Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat)?

    Cyclerion Therapeutics (Rights to Develop and Commercialize Praliciguat) was acquired by Akebia Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process